Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS

Clinical trial NCT05349721 · TERMINATED

Trial details

NCT number: NCT05349721
Sponsor: PTC Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2022-05-15
Primary completion: 2024-09-26
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.